Reversing Atherosclerosis With Aggressive Lipid Lowering - REVERSAL


The goal of the trial was to evaluate the effect of treatment with an aggressive lipid-lowering strategy with atorvastatin versus a moderate lipid-lowering strategy with pravastatin on coronary atherosclerosis progression assessed using intravascular ultrasound (IVUS) in patients with symptomatic coronary artery disease (CAD) and elevated LDL.